Broker Newswire
  • Home
  • Latest News
  • Investing
    • Acquisitions
    • Broker Related
    • Online Trading
    • Cryptocurrencies
    • Stocks
  • Markets
    • Earnings
    • OTC Markets
    • Penny Stocks
  • Personal Finance
    • Saving money
    • Retirement
  • Economy
  • Tech
    • Enterprise
    • Internet
SUBSCRIBE
No Result
View All Result
  • Home
  • Latest News
  • Investing
    • Acquisitions
    • Broker Related
    • Online Trading
    • Cryptocurrencies
    • Stocks
  • Markets
    • Earnings
    • OTC Markets
    • Penny Stocks
  • Personal Finance
    • Saving money
    • Retirement
  • Economy
  • Tech
    • Enterprise
    • Internet
No Result
View All Result
Broker Newswire
No Result
View All Result
Home Latest News General

Zymeworks Opens New Lab Facility In Vancouver Canada

by Jay Helton
January 30, 2017
1 min read
0
zymeworks pipeline
Share on FacebookShare on Twitter

RELATED STORIES

Volkswagen must pay damages

Volkswagen must pay damages to buyers of manipulated diesel cars

May 25, 2020
Future Cloud Banking and Fintech

Future Cloud Predictions for Banking and Fintech Sector

April 23, 2020

On January the 25th, Zymeworks announced the opening of their new state-of-the-art laboratory in Vancouver, Canada. The company, which is solely dedicated to discovery and development of next-generational multi-functional biotherapeutics. At this point in time, the company is focused on developing treatments for cancer. Their new 10,000 square foot lab facility in Vancouver, Canada will undoubtedly be a valuable asset for their company. The company hopes the new lab will give them additional control over discovery research, antibody generation, and the creation of multi-functional proteins.

As pointed out by the company’s President and CEO, Dr. Ali Tehrani, the lab will allow Zymeworks to conduct their own internal research and development in a totally integrated manner. The clinical-stage biopharmaceutical company’s lead candidate is ZW25. The effectiveness of the novel bispecific antibody is currently being studied in an adaptive Phase 1 clinical trial. The company has also been working diligently to establish a pipeline of preclinical product candidates, as well as discovery-stage programs for immuno-oncology and other areas. To learn more about Zymeworks and their pipeline, be sure to check out their official website at www.zymeworks.com.

Tags: canadacancervancouverzymeworks
Create your Web Presence with Namecheap

Recent Posts

  • Bitcoin and crypto spending is allowed by PayPal Now
  • The event in the live stream: Apple releases 5G-capable iPhone – Business
  • Volkswagen thriller: An unpopular supplier, audio recordings and a dead man
  • Tencent and WeChat also affected: Why Trump’s TikTok ban could harm Silicon Valley
  • Hacker attack on Twitter: “Group of young people” is supposed to be behind the attack on the social media platform

Category

  • Acquisitions
  • Broker Related
  • Earnings Reports
  • Economy
  • Enterprise
  • General
  • Internet
  • Investing
  • IPO News
  • Latest News
  • Layoffs
  • Markets
  • Online Trading
  • Opinion
  • OTC Markets
  • Penny Stocks
  • Personal Finance
  • Retirement
  • Saving money
  • Stocks
  • Technology

About Us

Broker Newswire (BN) is an exciting new online publication, which targets finances, brokers, mortgage and markets. BN, which is the nation’s leading provider of real estate, finance and market news and analysis.

  • About
  • Advertise
  • Privacy & Policy
  • Feedback

© 2021 JNews - Premium WordPress news & magazine theme by Jegtheme.

No Result
View All Result
  • Home
  • Latest News
  • Investing
    • Acquisitions
    • Broker Related
    • Cryptocurrencies
    • Online Trading
    • Stocks
  • Markets
    • Earnings Reports
    • OTC Markets
    • Penny Stocks
  • Personal Finance
    • Retirement
    • Saving money
  • Economy
  • Tech
    • Enterprise
    • Internet
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.